New: Introducing the Finviz Crypto Map

Learn More
Last Close
Jul 18 04:00PM ET
14.07
Dollar change
-7.89
Percentage change
-35.94
%
Index- P/E- EPS (ttm)-2.58 Insider Own4.89% Shs Outstand98.25M Perf Week-22.54%
Market Cap1.38B Forward P/E3.83 EPS next Y3.67 Insider Trans-0.05% Shs Float93.47M Perf Month-34.72%
Enterprise Value2.20B PEG- EPS next Q0.70 Inst Own90.26% Short Float15.71% Perf Quarter-73.91%
Income-248.39M P/S0.62 EPS this Y-256.61% Inst Trans-0.90% Short Ratio2.48 Perf Half Y-88.20%
Sales2.23B P/B1.21 EPS next Y207.50% ROA-7.43% Short Interest14.68M Perf YTD-88.42%
Book/sh11.63 P/C2.65 EPS next 5Y16.97% ROE-23.61% 52W High150.48 -90.65% Perf Year-90.55%
Cash/sh5.32 P/FCF- EPS past 3/5Y- - ROIC-9.99% 52W Low16.88 -16.62% Perf 3Y-82.21%
Dividend Est.- EV/EBITDA- Sales past 3/5Y39.42% 37.94% Gross Margin80.07% Volatility15.99% 8.44% Perf 5Y-91.66%
Dividend TTM- EV/Sales0.99 EPS Y/Y TTM-1881.09% Oper. Margin-5.25% ATR (14)2.47 Perf 10Y-50.25%
Dividend Ex-Date- Quick Ratio2.46 Sales Y/Y TTM59.15% Profit Margin-11.12% RSI (14)30.81 Recom2.30
Dividend Gr. 3/5Y- - Current Ratio4.02 EPS Q/Q-1361.33% SMA20-23.04% Beta0.46 Target Price43.00
Payout0.00% Debt/Eq1.18 Sales Q/Q80.15% SMA50-51.58% Rel Volume12.96 Prev Close21.97
Employees1372 LT Debt/Eq1.18 EarningsMay 06 AMC SMA200-83.60% Avg Volume5.91M Price14.07
IPOJun 04, 1997 Option/ShortYes / Yes EPS/Sales Surpr.-43.44% 8.35% Trades Volume76,568,720 Change-35.94%
Date Action Analyst Rating Change Price Target Change
TodayDowngrade Needham Buy → Hold
Jun-20-25Downgrade William Blair Outperform → Mkt Perform
Jun-18-25Downgrade TD Cowen Buy → Hold $24
Jun-17-25Initiated Wolfe Research Peer Perform
Jun-16-25Downgrade Piper Sandler Overweight → Neutral $36
Jun-16-25Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-16-25Downgrade H.C. Wainwright Neutral → Sell $10
Jun-16-25Downgrade Cantor Fitzgerald Overweight → Neutral
Jun-16-25Downgrade BofA Securities Buy → Neutral
Jun-16-25Downgrade BMO Capital Markets Outperform → Market Perform $70
Today 07:54PM
07:39PM
06:42PM
05:57PM
04:32PM
04:17PM Loading…
04:17PM
03:49PM
02:58PM
02:24PM
01:38PM
12:44PM
12:19PM
11:43AM
11:32AM
11:03AM
09:10AM Loading…
09:10AM
08:20AM
08:17AM
07:48AM
07:06AM
05:39AM
Jul-17-25 05:04PM
04:38PM
04:13PM
02:43PM
01:24PM
11:57AM
11:00AM
10:58AM
10:02AM
08:11AM Loading…
08:11AM
06:03AM
05:24AM
05:18AM
04:41AM
Jul-16-25 11:34PM
05:39PM
05:30PM
05:00PM
04:01PM
12:23PM
12:18PM
Jul-15-25 08:58AM
Jul-11-25 09:00AM
Jul-10-25 01:51PM
Jun-30-25 06:26PM
Jun-27-25 08:15AM
Jun-25-25 01:33PM
01:01PM
Jun-24-25 03:09PM
10:20AM
Jun-20-25 04:08PM
11:56AM
11:56AM
11:27AM
Jun-19-25 09:45AM
03:00AM
Jun-18-25 11:39AM
09:51AM
Jun-17-25 09:35AM
09:23AM
09:16AM
06:20AM
Jun-16-25 05:07PM
04:19PM
04:13PM
04:05PM
03:51PM
03:15PM
02:31PM
01:37PM
12:30PM
12:19PM
11:59AM
11:10AM
10:24AM
09:12AM
08:45AM
08:00AM
07:55AM
06:18AM
05:18AM
05:17AM
Jun-15-25 01:00AM
Jun-10-25 12:31PM
12:38AM
Jun-07-25 09:40AM
Jun-05-25 05:39PM
11:31AM
10:03AM
Jun-04-25 01:00PM
09:30AM
May-27-25 10:03AM
May-22-25 06:52AM
May-21-25 08:30AM
May-19-25 10:04AM
07:36AM
May-16-25 09:01AM
09:00AM
May-14-25 08:30AM
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Barry RichardDirectorMay 16 '25Option Exercise32.6312,350402,9812,966,667May 19 07:32 AM
Barry RichardDirectorMay 13 '25Option Exercise19.2320,246389,3592,954,317May 15 07:00 AM
Nicaise ClaudeDirectorMar 12 '25Option Exercise25.189,746245,40430,303Mar 13 08:00 PM
Nicaise ClaudeDirectorMar 12 '25Sale99.642,491248,20327,812Mar 13 08:00 PM
Nicaise ClaudeDirectorMar 12 '25Proposed Sale99.652,491248,226Mar 12 05:33 PM
Estepan Ian MichaelChief Financial OfficerJan 29 '25Option Exercise12.0015,800189,60049,496Jan 31 08:30 PM
Wigzell Hans Lennart RudolfDirectorDec 12 '24Option Exercise13.7110,500143,95533,340Dec 16 08:00 PM
Wigzell Hans Lennart RudolfDirectorDec 12 '24Sale124.8410,5001,310,82022,840Dec 16 08:00 PM
Wigzell Hans Lennart RudolfDirectorDec 12 '24Proposed Sale124.8010,5001,310,400Dec 12 05:06 PM
Boor Kathryn JeanDirectorDec 05 '24Sale125.551,636205,4005,880Dec 06 08:00 PM
Boor Kathryn JeanDirectorDec 05 '24Proposed Sale125.551,636205,400Dec 05 04:18 PM
Estepan Ian MichaelChief Financial OfficerAug 30 '24Sale137.365,985822,10033,946Sep 03 08:00 PM
Estepan Ian MichaelOfficerAug 30 '24Proposed Sale137.375,985822,130Aug 30 05:03 PM
Chambers Michael AndrewDirectorAug 16 '24Buy133.8037,0384,955,728284,034Aug 20 08:00 AM